The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Atypical Hyperplasia of the Breast — Risk Assessment and Management Options
Open accessAbstract
The criteria for inclusion in the table were a central pathological review and the use of the criteria of David Page and colleagues for the diagnosis of atypical hyperplasia.9 CI denotes confidence interval.† The study was a retrospective cohort study involving women who had excisional biopsies performed during the period 1950 -1968.The median duration of follow-up was 17 years.Risk estimates are for invasive breast cancer only.‡ The study was a retrospective cohort study involving women who had excisional biopsies, core biopsies, or both performed during the period 1967-2001.The median duration of follow-up was 12.1 years.Risk estimates are for both invasive and in situ breast cancer (19% of cases were in situ).The numbers of patients in subcategories may not add to the total because information was missing for some patients.§ A strong family history was defined as at least one first-degree relative with breast cancer before 50 years of age or two or more relatives with breast cancer, with at least one being a first-degree relative.A weak family history was defined as any lesser degree of family history.¶ The study was a retrospective cohort study involving women who had biopsies performed during the period 1981-1994.The duration of follow-up was not specified.Risk estimates are for both invasive and in situ breast cancer (20% of cases were in situ).‖ The study was a nested case-control study.The type of breast cancer (i.e., invasive or in situ) evaluated for the risk estimates was not specified.** The study was a nested case-control study; risk estimates are for both invasive and in situ breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829
Self-citationA breast cancer prediction model incorporating familial and personal risk factors
Tyrer, J., Duffy, S. W., & Cuzick, J. (2004) · Statistics in Medicine · doi:10.1002/sim.1668 · Cited by 1,345
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., McTiernan, A., Robbins, J., Johnson, K. C., Martin, L. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103507 · Cited by 970
Atypical hyperplastic lesions of the female breast. A long-term follow-up study
Page, D. L., Dupont, W. D., Rogers, L. W., & Rados, M. S. (1985) · Cancer · doi:10.1002/1097-0142(19850601)55:11<2698::aid-cncr2820551127>3.0.co;2-a · Cited by 961
Self-citationBenign Breast Disease and the Risk of Breast Cancer
Hartmann, L. C., Sellers, T. A., Frost, M. H., Lingle, W. L., Degnim, A. C., Ghosh, K., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., Hillman, D. W., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044383 · Cited by 938
Self-citationPowles, T. (1998) · The Lancet · doi:10.1016/s0140-6736(98)05071-5 · Cited by 902
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
Lee, C. H., Dershaw, D. D., Kopans, D., Evans, P., Monsees, B., Monticciolo, D., Brenner, R. J., Bassett, L., Berg, W., Feig, S., et al. (2010) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2009.09.022 · Cited by 809
Veronesi, U. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04394-3 · Cited by 804
Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer Incidence
Costantino, J. P., Gail, M. H., Pee, D., Anderson, S., Redmond, C. K., Benichou, J., & Wieand, H. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1541 · Cited by 765
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09962-2 · Cited by 747
Martino, S., Cauley, J. A., Barrett-Connor, E., Powles, T. J., Mershon, J., Disch, D., Secrest, R. J., Cummings, S. R., & For the CORE Investigators (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh319 · Cited by 684
Cauley, J. A., Norton, L., Lippman, M. E., Eckert, S., Krueger, K. A., Purdie, D. W., Farrerons, J., Karasik, A., Mellstrom, D., Ng, K. W., et al. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006478317173 · Cited by 678
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., & Vogel, V. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1829 · Cited by 670
Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Wade, J. L., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0076 · Cited by 646
Cuzick, J., Sestak, I., Forbes, J. F., Dowsett, M., Knox, J., Cawthorn, S., Saunders, C., Roche, N., Mansel, R. E., von Minckwitz, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62292-8 · Cited by 590
Cuzick, J., Forbes, J. F., Sestak, I., Cawthorn, S., Hamed, H., Holli, K., & Howell, A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk049 · Cited by 534
A Prospective Study of Benign Breast Disease and the Risk of Breast Cancer
London, S. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480070057030 · Cited by 504
Cuzick, J., Sestak, I., Bonanni, B., Costantino, J. P., Cummings, S., DeCensi, A., Dowsett, M., Forbes, J. F., Ford, L., LaCroix, A. Z., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60140-3 · Cited by 495
The molecular pathology of breast cancer progression
Bombonati, A., & Sgroi, D. C. (2011) · The Journal of Pathology · doi:10.1002/path.2808 · Cited by 455
Powles, T. J., Ashley, S., Tidy, A., Smith, I. E., & Dowsett, M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk050 · Cited by 430
Histological and biological evolution of human premalignant breast disease.
Allred, D. C., Mohsin, S. K., & Fuqua, S. A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080047 · Cited by 416
Schnitt, S. J., Connolly, J. L., Tavassoli, F. A., Fechner, R. E., Kempson, R. L., Gelman, R., & Page, D. L. (1992) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199212000-00001 · Cited by 409
Cuzick, J., Warwick, J., Pinney, E., Duffy, S. W., Cawthorn, S., Howell, A., Forbes, J. F., & Warren, R. M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr079 · Cited by 405
Allred, D. C., Anderson, S. J., Paik, S., Wickerham, D. L., Nagtegaal, I. D., Swain, S. M., Mamounas, E. P., Julian, T. B., Geyer, C. E., Costantino, J. P., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.0141 · Cited by 361
Santen, R. J., & Mansel, R. (2005) · New England Journal of Medicine · doi:10.1056/nejmra035692 · Cited by 358
Self-citationBreast cancer precursors revisited: molecular features and progression pathways
Lopez‐Garcia, M. A., Geyer, F. C., Lacroix‐Triki, M., Marchió, C., & Reis‐Filho, J. S. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03568.x · Cited by 347
Page, D. L., Schuyler, P. A., Dupont, W. D., Jensen, R. A., Plummer, W. D., & Simpson, J. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12230-1 · Cited by 334
Self-citationVisvanathan, K., Hurley, P., Bantug, E., Brown, P., Col, N. F., Cuzick, J., Davidson, N. E., DeCensi, A., Fabian, C., Ford, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.3122 · Cited by 307
Fitzgibbons, P. L., Henson, D. E., & Hutter, R. V. P. (1998) · PubMed · Cited by 276
Stratification of Breast Cancer Risk in Women With Atypia: A Mayo Cohort Study
Degnim, A. C., Visscher, D. W., Berman, H. K., Frost, M. H., Sellers, T. A., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., de Groen, P. C., Lingle, W. L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0217 · Cited by 270
Self-citationHartmann, L. C., Radisky, D. C., Frost, M. H., Santen, R. J., Vierkant, R. A., Benetti, L. L., Tarabishy, Y., Ghosh, K., Visscher, D. W., & Degnim, A. C. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0222 · Cited by 234
Self-citationPatient Reluctance Toward Tamoxifen Use for Breast Cancer Primary Prevention
Port, E. R., Montgomery, L. L., Heerdt, A. S., & Borgen, P. I. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0580-9 · Cited by 196
Freedman, A. N., Yu, B., Gail, M. H., Costantino, J. P., Graubard, B. I., Vogel, V. G., Anderson, G. L., & McCaskill-Stevens, W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0258 · Cited by 191
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010
Waters, E. A., McNeel, T. S., Stevens, W. M., & Freedman, A. N. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2089-2 · Cited by 181
A prospective study of benign breast disease and the risk of breast cancer
London, S. J. (1992) · JAMA · doi:10.1001/jama.267.7.941 · Cited by 178
Boughey, J. C., Hartmann, L. C., Anderson, S. S., Degnim, A. C., Vierkant, R. A., Reynolds, C. A., Frost, M. H., & Pankratz, V. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0784 · Cited by 143
Self-citationResults of MRI Screening for Breast Cancer in High-Risk Patients with LCIS and Atypical Hyperplasia
Port, E. R., Park, A., Borgen, P. I., Morris, E. A., & Montgomery, L. L. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9195-5 · Cited by 123
Giuliano, A. E., Boolbol, S. K., Degnim, A. C., Kuerer, H. M., Leitch, A. M., & Morrow, M. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9447-z · Cited by 116
Self-citationArzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women
Cummings, S. R., McClung, M. R., Reginster, J., Cox, D., Mitlak, B., Stock, J. L., Amewou-Atisso, M. G., Powles, T. J., Miller, P. D., Zanchetta, J., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.191 · Cited by 111
Assessment of the Accuracy of the Gail Model in Women With Atypical Hyperplasia
Pankratz, V. S., Hartmann, L. C., Degnim, A. C., Vierkant, R. A., Ghosh, K., Vachon, C. M., Frost, M. H., Maloney, S. D., Reynolds, C. A., & Boughey, J. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8833 · Cited by 108
Self-citationFactors affecting breast cancer risk reduction practices among California physicians
Kaplan, C. P., Haas, J. S., Pérez‐Stable, E. J., Jarlais, G. D., & Gregorich, S. E. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.09.041 · Cited by 88
Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions
Gutwein, L. G., Ang, D. N., Liu, H., et al. (2011) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2010.09.005 · Cited by 82
Is 'fibrocystic disease' of the breast precancerous?
Se, G. (1986) · PubMed · Cited by 77
Taylor, R., & Taguchi, K. (2005) · The Annals of Family Medicine · doi:10.1370/afm.284 · Cited by 73
Lobule type and subsequent breast cancer risk: Results from the Nurses' Health Studies
Baer, H. J., Collins, L. C., Connolly, J. L., et al. (2009) · Cancer · doi:10.1002/cncr.24167 · Cited by 59
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene
Powles, T. J., Diem, S. J., Fabian, C. J., Neven, P., Wickerham, D. L., Cox, D. A., Muram, D., Agnusdei, D., Dowsett, S. A., Amewou-Atisso, M. G., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2041-5 · Cited by 50
Breast Cancer Prevention: Patient Decision Making and Risk Communication in the High Risk Setting
Ozanne, E. M., Wittenberg, E., Garber, J. E., & Weeks, J. C. (2009) · The Breast Journal · doi:10.1111/j.1524-4741.2009.00857.x · Cited by 33
Benign Breast Disease and the Risk of Breast Cancer
Hartmann, L. C., Sellers, T. A., Frost, M. H., Lingle, W. L., Degnim, A. C., Ghosh, K., Vierkant, R. A., Maloney, S. D., Pankratz, V. S., Hillman, D. W., et al. (2016) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000489578.68399.d7 · Cited by 26
Self-citationBreast Cancer Risk Reduction Clinical Practice Guidelines in Oncology
(2003) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2003.0026 · Cited by 14
Rueth, N. M., McMahon, M., Arrington, A. K., Swenson, K. K., Leach, J. W., & Tuttle, T. M. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1642-2 · Cited by 4
Cited by
Coates, A. S., Winer, E. P., Goldhirsch, A., Gelber, R. D., Gnant, M., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., André, F., Baselga, J., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv221 · Cited by 1,827
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens
Elmore, J. G., Longton, G. M., Carney, P. A., Geller, B. M., Onega, T., Tosteson, A. N. A., Nelson, H. D., Pepe, M. S., Allison, K. H., Schnitt, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.1405 · Cited by 751
“001 Atypia 72 2070 17 (15-21) 35 (31-39) 48 (44-52)”
Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002158 · Cited by 258
Metadata
- Authors
- Hartmann, L. C., Degnim, A. C., Santen, R. J., Dupont, W. D., & Ghosh, K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-01-01
- Volume
- 372
- Issue
- 1
- Pages
- 78-89
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2049869682
- Cited by
- 366
- References
- 57
- FWCI
- 20.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.